Search results
Results from the WOW.Com Content Network
Wyeth and Ayerst merged to form Wyeth-Ayerst Laboratories, thus strengthening and consolidating Wyeth's pharmaceutical operations. In the late 1980s, Wyeth acquired the animal health businesses of Bristol-Myers and Parke-Davis .
Bristol-Myers Squibb and Otsuka American: Off-label promotion of Abilify, September 2007 [ edit ] In a settlement totaling $515 million to settle a host of civil charges and civil liabilities related to alleged illegal pricing and marketing practices for several of its drugs, Bristol-Myers Squibb paid out approximately $50 million to settle ...
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
The drugmaker said it would focus on licensing, partnerships and bolt-on purchases as opposed to large acquisitions after signing two multi-billion dollar deals last month. In December, Bristol ...
Lighter Side. Medicare. News
Bristol Myers has already faced pressure from generic competition for Revlimid, once its top-selling drug. Current top seller Eliquis is expected to have revenue somewhat curtailed when the U.S ...
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey , [ 2 ] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
Bristol-Myers Squibb announced a $2 billion share buyback program, sending shares of the biopharmaceutical company up 4% on Monday.Bristol-Myers’ (BMY) additional share buyback plan brings the ...